Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial
- DOI
- 10.1016/s0140-6736(26)01424-8
- Published
- 2026-09
- Container
- The Lancet
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-26-01424-8,
title = {Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial},
author = {Peter Holger Johnsen and Frederik Emil Juul and Dag Arne Lihaug Hoff and Eline Randulff Hillestad and Øyvind Holme and Linn Kallbekken Skjevling and Hege Marie Hansen and Marthe H Rasmus and Lauren Barnett and Sarah J E Barry and Erik Hjerde and Kenneth Lindstedt and Dorota J Buczek and Jan G Hatlebakk and Elisabeth K Steinsvik and Birgitte Berentsen and Kjetil Kjeldstad Garborg and Jørgen Valeur and Per Christian Valle and Magnus Løberg and Mette Kalager and Michael Bretthauer and Rasmus Goll},
year = {2026},
journal = {The Lancet},
doi = {10.1016/s0140-6736(26)01424-8},
url = {https://doi.org/10.1016/s0140-6736(26)01424-8}
}RIS
TY - JOUR TI - Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial AU - Peter Holger Johnsen AU - Frederik Emil Juul AU - Dag Arne Lihaug Hoff AU - Eline Randulff Hillestad AU - Øyvind Holme AU - Linn Kallbekken Skjevling AU - Hege Marie Hansen AU - Marthe H Rasmus AU - Lauren Barnett AU - Sarah J E Barry AU - Erik Hjerde AU - Kenneth Lindstedt AU - Dorota J Buczek AU - Jan G Hatlebakk AU - Elisabeth K Steinsvik AU - Birgitte Berentsen AU - Kjetil Kjeldstad Garborg AU - Jørgen Valeur AU - Per Christian Valle AU - Magnus Løberg AU - Mette Kalager AU - Michael Bretthauer AU - Rasmus Goll PY - 2026 JO - The Lancet DO - 10.1016/s0140-6736(26)01424-8 UR - https://doi.org/10.1016/s0140-6736(26)01424-8 ER -
APA
Johnsen, P. H., Juul, F. E., Hoff, D. A. L., Hillestad, E. R., Holme, Ø., Skjevling, L. K., Hansen, H. M., Rasmus, M. H., Barnett, L., Barry, S. J. E., Hjerde, E., Lindstedt, K., Buczek, D. J., Hatlebakk, J. G., Steinsvik, E. K., Berentsen, B., Garborg, K. K., Valeur, J., Valle, P. C., Løberg, M., Kalager, M., Bretthauer, M., & Goll, R. (2026). Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. https://doi.org/10.1016/s0140-6736(26)01424-8
Source records
- crossref · retrieved 2026-09-25T20:30:53.963Z